0001139685 1 2026-04-03 2026-04-03 0001139685 2 2026-04-03 2026-04-03 0001139685 3 2026-04-03 2026-04-03 0001139685 4 2026-04-03 2026-04-03 0001139685 2026-04-03 2026-04-03 iso4217:USD pure shares S-1 EX-FILING FEES 0001139685 N/A N/A S-1 20/20 BIOLABS, INC. false Equity Common Stock, $0.01 par value, issued to the selling stockholder true 475000 1.81 859750.00 0.0001381 118.73 false Equity Common Stock, $0.01 par value, issuable to the selling stockholder upon conversion of secured convertible promissory note true 42500 1.81 76925.00 0.0001381 10.62 false Equity Common Stock, $0.01 par value, issuable to the selling stockholder upon exercise of outstanding warrants true 62500 1.81 113125.00 0.0001381 15.62 false Equity Common Stock, $0.01 par value, that may be issued to the selling stockholder upon the conversion of shares of series E convertible preferred stock that may be issued to the selling stockholder true 9525000 1.81 17240250.00 0.0001381 2380.88 18290050.00 2525.85 0.00 0.00 2525.85 Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.<br/> Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.<br/> Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.<br/> Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.